Articles

Paratek Articles

September 9, 2020BenzingaNews

Paratek Pharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference

BOSTON, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK), a commercial-... See more »
September 1, 2020BioSpaceNews

Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Sep 01, 2020

Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the developmen... See more »
August 12, 2020MarketScreenerNews

Wedbush Conference August 2020

(marketscreener.com) QIDP ...https://www.marketscreener.com/PARATEK-PHARMACEUTICALS-18426416/news/Par... See more »
August 10, 2020NewsOkNews

2Q Earnings Snapshot

BOSTON (AP) _ Paratek Pharmaceuticals Inc. (PRTK) on Monday reported a loss of $23.1 million in its s... See more »
June 15, 2020Market ExclusiveNews

PARATEK PHARMACEUTICALS, INC. (NASDAQ:PRTK) Files An 8-K Submission of Matters to a Vote of Security Holders

PARATEK PHARMACEUTICALS, INC. (NASDAQ:PRTK) Files An 8-K Submission of Matters to a Vote of Security ... See more »
June 4, 2020FiercePharmaNews

As U.S. calls for stateside manufacturing, antibiotic maker Paratek gambles on 'onshoring' effort

As U.S. calls for stateside manufacturing, antibiotic maker Paratek gambles on 'onshoring' effort kbl... See more »
May 29, 2020GlobeNewswirePress Release

Paratek Pharmaceuticals Announces Change to Time of 2020 Annual Meeting of Stockholders

BOSTON, May 29, 2020 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-s... See more »
May 28, 2020BenzingaNews

Paratek Pharmaceuticals to Present at Jefferies 2020 Virtual Healthcare Conference

BOSTON, May 28, 2020 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK), a commercial-st... See more »
May 14, 2020Seeking AlphaNews

Paratek Plods Along

May 13, 2020MarketScreenerNews

Bank of America Securities 2020 Health Care Conference

(marketscreener.com) QIDP ABSSSI - QIDP ...https://www.marketscreener.com/PARATEK-PHARMACEUTICALS-184... See more »
April 30, 2020GlobeNewswirePress Release

Paratek Pharmaceuticals to Report First Quarter 2020 Financial Results on May 11, 2020

BOSTON, April 30, 2020 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial... See more »
February 26, 2020GlobeNewswirePress Release

Paratek Pharmaceuticals to Present at the SVB Leerink 9th Annual Global Healthcare Conference

BOSTON, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-... See more »
February 13, 2020GlobeNewswirePress Release

Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2019 Financial Results on February 25, 2020

BOSTON, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK), a commercial-... See more »
November 12, 2019GlobeNewswirePress Release

Paratek Pharmaceuticals Generates Net Revenues of $3.9 Million in the Third Quarter of 2019

-- Third Quarter 2019 NUZYRA® (omadacycline) Net Sales increased 82% versus the Prior Quarter to $3.1... See more »
November 4, 2019GlobeNewswirePress Release

Paratek Pharmaceuticals to Report Third Quarter 2019 Financial Results on November 12, 2019

BOSTON, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK), a commercial-... See more »
September 4, 2019GlobeNewswirePress Release

Paratek Pharmaceuticals to Present at the 21st Annual H.C. Wainwright Global Investment Conference

BOSTON, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK), a commercial... See more »
August 6, 2019GlobeNewswirePress Release

Paratek Pharmaceuticals Generates Net Revenues of $2.0 Million in the Second Quarter of 2019

-- NUZYRA® (omadacycline) Net Sales increased 26% to $1.7 Million in the Second Quarter of 2019 -- --... See more »
July 29, 2019GlobeNewswirePress Release

Paratek Pharmaceuticals to Report Second Quarter 2019 Financial Results on August 6, 2019

BOSTON, July 29, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK), a commercial-... See more »
May 8, 2019GlobeNewswirePress Release

Paratek's NUZYRA (omadacycline) Generates Net Sales of $1.3 Million in the First Eight Weeks on the U.S. Market

-- Approximately One Third of Commercial Lives in U.S. had Access to NUZYRA by the End of the First Q... See more »
Loading interface...
Loading interface...
Loading interface...
Loading interface...